The debate over extending enhanced Obamacare subsidies has dominated headlines, but the more urgent problem is runaway health care costs driven by hospital spending decisions, executive perks, and nonclinical ventures that ultimately push prices higher for families, employers, and taxpayers.
Lawmakers argue over Enhanced Premium Tax Credits and whether to prolong them, yet that fight misses a critical point: subsidies treat symptoms, not the underlying disease of high health care costs. From executive travel to celebrity marketing and pizza-parlor purchases, too many health systems are spending in ways that have nothing to do with patient care. When hospitals inflate nonclinical budgets, insurers push back or raise premiums, and everyday Americans pay the bill.
The enhanced subsidies were designed as temporary relief, but they became a political crutch that shields policymakers from confronting tough choices about what drives prices up. Families worry about premiums and out-of-pocket costs because the sticker price of health care keeps climbing faster than wages. Republicans have argued that helping people afford coverage matters, yet durability requires tackling supply-side waste and misaligned incentives.
A clear example of misplaced priorities shows up when nonprofit systems treat leadership like a corporate jet set. Hospitals such as Christus, Mercy, Montefiore, Ochsner, and SSM Health have been reported to book first-class flights or private jets and cover travel companions. Those lavish expenses look bad next to patients struggling with medical bills, and they raise honest questions about stewardship of nonprofit resources.
It’s not just travel. Some systems move into odd business ventures unrelated to medicine, using health-system balance sheets to buy buildings and operate restaurants or even hotels. Maine Medical acquiring a building with a pizza parlor and Ochsner running a hotel are examples of hospitals extending beyond core clinical missions. These moves create new cost centers and distract leadership from controlling clinical costs and improving efficiency.
Creative marketing also eats into budgets that ultimately affect prices. Monterey-style campaigns with celebrity spokespeople and high-end video production come at a price, and institutions like Montefiore have spent millions engaging creative agencies and producing splashy content. That kind of spending boosts brand recognition, but it does little to lower the cost of care or improve outcomes for most patients.
Some organizations even conduct activities far from the bedside—Mercy Health’s reported expenditures in distant regions raise eyebrows about whether such investments serve patient communities. When nonprofit hospitals stretch into global or exotic spending patterns, it fuels a narrative that institutional priorities have drifted. Conservatives rightly call out misaligned incentives when tax-exempt entities behave like diversified conglomerates.
Those spending patterns feed into tougher contract fights with insurers. Hospitals seeking reimbursement rate increases that “far exceed inflation” put pressure on payers, which in turn can lead insurers to narrow networks, hike premiums, or drop coverage agreements. The result is a lose-lose for consumers: either higher costs or reduced access to familiar providers—and politicians on both sides should care about both outcomes.
Across states from Oregon to Nebraska, Connecticut to Florida, high-profile disputes between major hospital systems and insurers have made headlines, showing that these issues are widespread and not confined to a single region. Health systems pushing for outsized rate hikes request more money from employers, government programs, and patients, and those hikes compound over time. The subsidy fight therefore cannot be decoupled from the larger question of why health care prices keep exploding.
A sensible Republican perspective accepts that people need affordable coverage but insists that subsidies are not a long-term fix if the cost base keeps growing. Accountability for nonprofit hospitals, clearer rules around executive compensation and travel, and a focus on pricing transparency would do more to lower premiums than temporary checks from Washington. Policy should reward efficiency and patient-centered care rather than subsidizing lavish, nonclinical spending.
Health care watchdogs and policymakers should prioritize real reforms that constrain price growth: eliminate perverse payment incentives, increase transparency around hospital charges and contracts, and scrutinize nonclinical ventures funded by tax-exempt entities. Those steps would reduce upward pressure on premiums and make any subsidy program more sustainable. Until that happens, taxpayers and patients will keep subsidizing wasteful spending through higher insurance costs and government outlays.
The subsidies debate matters, but it should be paired with vigorous oversight of how hospitals spend money and why providers demand higher reimbursement. Stopping excessive, unrelated, or luxury expenditures at large health systems would protect consumers and improve the odds that any assistance from Washington actually helps families afford care rather than masking deeper, structural problems that keep costs out of reach.
Add comment